[Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Perrone Filardi
P
P
Cattedra di Cardiologia, Università degli Studi Federico II, Napoli.
Chiariello
M
M
D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy / Q000503:physiopathology; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D020108:Nicorandil; D015221:Potassium Channels / Q000819:agonists* / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D015221:Potassium Channels; D014665:Vasodilator Agents; D009536:Niacinamide; D020108:Nicorandil